Join GitHub today
GitHub is home to over 40 million developers working together to host and review code, manage projects, and build software together.Sign up
Problems on skin permeation model in MoBi #466
I have been trying to build a simulation for transdermal application of fentanyl patch using the launched skin permeation model in MoBi. Based on the User’s Guide, I was able to create simulations for testosterone and connecting the model to a whole-body model generated in PK-Sim.
My next step was then to apply the skin model to a whole body fentanyl PBPK model to investigate venous blood concentrations of fentanyl after the patch application.
Unfortunately, I am not being able to get it right!
First problem, since my fentanyl whole-body PBPK model takes into account fentanyl metabolism by CYP3A4, after merging whole_body_simulation and skin_simulation my "Molecules Building Block" shows not only fentanyl but also CYP3A4 and its metabolite.
Because of that, every time I try to create a new simulation, CYP3A4 molecule appears in the “Molecule Start Values” for the Path Element “Dermal_application_Area” and I have to manually unchecked all the box “Is present” in order to make the simulation work (Figure bellow).
How could I solve this problem? Is this a problem during the process of merging the two simulations?
Another point I would like to address, after being able to simulate the patch administration, it is clear that I am not capturing the observed venous profile correctly. (Observed data from: https://accp1.onlinelibrary.wiley.com/doi/epdf/10.1177/0091270006286901).
I was thinking about optimize the bloodstream clearance amount (Qabs) and the maximum rate of dermis to bloodstream clearance amount (Jmax).
However, I was not able to find those two parameters in my simulation tree. Are they only available for in vitro simulations?
Finally, how can I simulate a multiple dosing regimen using this model? For example, the transdermal systems being replaced every 72 hours.
Could you please, give me your thoughts, answers, or input?
Thank you so much,
I am not an expert on this problem, however I have implemented a skin permeation model in MoBi once. These are my thoughts to things:
Everytime you create a new simulation, you can get rid of unchecking the box by the following protocol:
In MoBi, You have the
For the Qabs and Jmax, how have you implemented them in the model? Usually, I implement them as global parameters so that I can easily find the path.
The multiple dosing part, I am not the best one to answer this, you might find a way in #305 ?
Hope I was of help!
Thanks for your help! I was able to get rid of unchecking the box following the protocol and also figured out how to obtain the Qabs and Jmax parameters.
Also, I was able to simulate multiple dosing using the Events building block shared by @abdullahhamadeh .
However, as we can see in the drug concentration-time profile bellows it seems that there is no drug accumulation in between doses. Am I doing something wrong?
Also, I don't understand why I'm having this flat profile between 20 and 50 h after dose. I tried to optimize the diffusion process of stratum corneum, epidermis and dermis but did not work. Do you have any comments about that?
Glad that it worked out!
From the looks of it the clearance from the blood is fast enough to not allow for accumulation. There are couple of ways of moving forward from my perspective. I would tweak some parameters and see their consequence on the model:
If you are open to sharing your model, please do so and I will try to look into it too to help! :)